TICAROS Co., Ltd
PrivateLast Round
Series D
Mar 3, 2026
Est. Valuation
$197.42M
Total Funding Raised
$42.5M
Company Overview
TICAROS Co., Ltd is a biotechnology company that develops next-generation CAR-T and CAR-NK cell therapies for cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
CAR-T therapycell therapyimmunotherapycancer treatmentsolid tumor therapybiotechnologydrug discoveryclinical trialsprecision medicinenext-gen CAR-Tbiotech startupCDMOhematological malignancy
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TICAROS Co., Ltd Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
TICAROS Co., Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 3, 2026 | ||||
| Series C | Aug 24, 2021 | ||||
| Series B | Jan 9, 2020 | ||||
| Series A | Feb 1, 2019 |
TICAROS Co., Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KIWOOM Securities Co., Ltd. | Series D |
| Shinhan Venture Investment | Series C |
| iM Investment Partners | Series D |
| Kingo Investment Partners | Series C |
| UTC Investment | Series C |
| Medici Investment | Series C |
| Daesung Private Equity | Series C |
TICAROS Co., Ltd Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TICAROS Co., Ltd's valuation, stock price, and market status.